The Europe Bioinformatics Market would witness market growth of 12.3% CAGR during the forecast period (2022-2028).
Combining molecular and chemical methods, bioinformatics approaches are used in the search for natural compounds. The ability to conduct a large-scale screening and phylogenetic resolution are crucial molecular approach characteristics. Understanding the genetic and epigenetic elements of various bacterial taxa requires the use of comparative genome sequence analysis. The rising number of completely sequenced microbial genomes, such as those from well-known bacterial manufacturers of natural products, has made it obvious that these microbes have significantly greater genomic and metabolic capacities than once thought. This is because "silent" or "cryptic" secondary metabolite gene clusters have been found, which code for the creation of extra, undiscovered chemicals.
Prenatal genetic screening systems are expected to increase rapidly in the near future. This is due to the fact that these programs assist pregnant moms in detecting genetic abnormalities in their children. Moreover, it is anticipated that in the next ten years, every newborn’s genome will be sequenced and stored in the electronic medical record. Emerging companies like Counsyl and Natera have released several genetic tests to get a competitive advantage in the industry, gauging the future market potential of genomics in newborn screening programs.
With the intention of sequencing 100,000 human genomes, developing a genomic medicine service for the NHS, and facilitating new scientific discoveries, the UK government unveiled the 100,000 Genomes Project in 2012. It has over £200 million in financing and will first concentrate on cancer and uncommon illnesses. Therefore, it is anticipated that these variables will provide new development opportunities for the local genomics market throughout the forecasted period.
The Germany market dominated the Europe Bioinformatics Market by Country in 2021; thereby, achieving a market value of $1.3 Billion by 2028. The UK market is anticipated to grow at a CAGR of 11.4% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 13.1% during (2022 - 2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Bioinformatics Market will Hit $19.9 Billion by 2028, at a CAGR of 12.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
By Product & Services
By Sector
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
